心血管代谢多病、生活方式行为与认知功能:多队列研究
该多队列研究汇总四个队列共160 147名50岁及以上参与者,发现心血管代谢疾病数量与认知功能评分下降呈剂量依赖性关联。体力活动不足、过量饮酒及不健康生活方式因素数量较多会加速该认知下降。研究者建议针对生活方式与心血管代谢共病开展综合干预以延缓老年人认知衰退。
要点
- 心血管代谢疾病数量越多,认知功能评分下降越显著,呈剂量依赖性。
- 体力活动不足和过量饮酒可加速心血管代谢疾病相关的认知下降。
- 不健康生活方式因素数量较多与两种心血管代谢疾病患者的认知下降加速相关。
核心结论
- 心血管代谢多病与认知功能评分下降呈剂量依赖性关联。
- 体力活动不足、过量饮酒及不健康生活方式因素数量较多可加速心血管代谢疾病相关的认知下降。
- 研究提示可同时针对生活方式和心血管代谢共病开展综合干预以延缓老年人认知衰退。
研究设计与样本
- 汇总四个队列(HRS、ELSA、SHARE、CHARLS)覆盖14个国家的多队列研究。
- 纳入50岁及以上参与者,排除暴露和结局信息缺失者及已诊断痴呆或帕金森病者。
- 心血管代谢多病定义为糖尿病、心脏病和卒中中两种或三种共存。
- 主要结局为认知功能三个域(记忆、计算、定向)及总分。
临床怎么用
- 关注心血管代谢多病老年人的认知功能,疾病数量越多认知下降风险越高。
- 评估并干预体力活动不足和过量饮酒等生活方式因素,可能有助于延缓认知下降。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known about the effect of lifestyle factors on cognitive decline related to cardiometabolic multimorbidity. We aimed to examine the association between cardiometabolic multimorbidity and cognitive decline, and the role of lifestyle factors in this association. METHODS: We did a pooled multi-cohort study using pooled data from four cohort studies (the Health and Retirement Study; the English Longitudinal Study of Ageing; the Survey of Health, Ageing and Retirement in Europe; and the China Health and Retirement Longitudinal Study) across 14 countries. Eligible participants were age 50 years and older, and those who were missing information on exposure and outcomes, or who had been diagnosed with dementia or Parkinson's disease, were excluded. Cardiometabolic multimorbidity was defined as the co-occurrence of two or three cardiometabolic diseases, including diabetes, heart disease, and stroke. The primary outcome of cognitive function was measured in three domains, on the basis of the mean and SD of the corresponding tests: memory, numeracy, and orientation, in all participants with available data. A global cognitive score was created by summing the individual scores. FINDINGS: The final sample consisted of 160 147 individuals across all four studies (73 846 [46·1%] men and 86 301 [53·9%] women) and participants had a mean age of 67·49 years (SD 10·43). An increasing number of cardiometabolic diseases was dose-dependently associated with the decline in cognitive function score (one disease, β=-0·15 [95% CI -0·17 to -0·13]; two diseases, β=-0·37 [-0·40 to -0·34]; three diseases, β=-0·57 [-0·64 to -0·50]), with comorbid diabetes and stroke (β=-0·23 [-0·29 to -0·17]) contributing most strongly to cardiometabolic disease-associated cognitive decline. Cognitive decline associated with cardiometabolic disease was accelerated with physical inactivity (one cardiometablic disease, p=0·020; two cardiometablic diseases, p=0·42; and three cardiometablic diseases, p=0·24), excessive alcohol use (one cardiometablic disease, p=0·016; two cardiometablic diseases, p=0·65; and three cardiometablic diseases, p=0·50), and the higher number of unhealthy lifestyle factors (one cardiometablic disease, p=0·79; two cardiometablic diseases, p=0·0050; and three cardiometablic diseases, p=0·888). INTERPRETATION: These findings indicated a targeted approach for simultaneously developing preventative interventions on lifestyles and integrated treatment for cardiometabolic comorbidities to delay cognitive decline in older people. FUNDING: Major Project of the National Social Science Fund of China, National Natural Science Foundation of China, China Medical Board, and Young Elite Scientists Sponsorship Program by CAST.
引用
- Jin Y, Liang J, Hong C, et al. Cardiometabolic multimorbidity, lifestyle behaviours, and cognitive function: a multicohort study. Lancet Healthy Longev. 2023. PMID: 37150183. doi:10.1016/S2666-7568(23)00054-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。